# Sorafenib in Treating Patients With Advanced Solid Tumors

> **NCT00436579** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 110 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** sorafenib tosylate
- **OTHER:** pharmacological study
- **PROCEDURE:** assessment of therapy complications
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00436579
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2011-09
- **Final completion:** —
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2014-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00436579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00436579, "Sorafenib in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00436579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*